These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9444891)

  • 1. Fluvoxamine in selective mutism.
    Lafferty JE; Constantino JN
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):12-3. PubMed ID: 9444891
    [No Abstract]   [Full Text] [Related]  

  • 2. More on fluvoxamine and enuresis.
    Kano K; Arisaka O
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):865. PubMed ID: 11501679
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.
    Sevincok L; Uslu A; Kaynak H; Dereboy F
    J Psychiatry Neurosci; 2000 Mar; 25(2):185. PubMed ID: 10740992
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa.
    Ikenouchi-Sugita A; Yoshimura R; Hori H; Ueda N; Nakamura J
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):452. PubMed ID: 17610677
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased sexual desire during fluvoxamine treatment.
    Okada F; Okajima K
    Can J Psychiatry; 2000 Oct; 45(8):762-3. PubMed ID: 11086562
    [No Abstract]   [Full Text] [Related]  

  • 6. What is the optimal approach to the pharmacological management of obsessive-compulsive disorder?
    Ravindran AV
    J Psychiatry Neurosci; 1998 Mar; 23(2):136. PubMed ID: 9549253
    [No Abstract]   [Full Text] [Related]  

  • 7. Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study.
    Cappiello A; McDougle CJ; Malison RT; Heninger GR; Price LH
    Biol Psychiatry; 1995 Dec; 38(11):765-7. PubMed ID: 8580232
    [No Abstract]   [Full Text] [Related]  

  • 8. New antidepressants.
    Kupecz D
    Nurse Pract; 1995 Sep; 20(9):64-7. PubMed ID: 7501318
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of fluvoxamine with warfarin in an elderly woman.
    Yap KB; Low ST
    Singapore Med J; 1999 Jul; 40(7):480-2. PubMed ID: 10560276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin.
    Jakob F; Wolf J
    Pharmacopsychiatry; 2007 May; 40(3):129. PubMed ID: 17541891
    [No Abstract]   [Full Text] [Related]  

  • 11. An open-label pilot study of fluvoxamine for mixed anxiety-depression.
    Houck C
    Psychopharmacol Bull; 1998; 34(2):225-7. PubMed ID: 9641005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial.
    Spivak B; Strous RD; Shaked G; Shabash E; Kotler M; Weizman A
    J Clin Psychopharmacol; 2006 Apr; 26(2):152-6. PubMed ID: 16633143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects.
    Grassi B; Gambini O; Scarone S
    Pharmacopsychiatry; 1995 May; 28(3):93-4. PubMed ID: 7568371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvoxamine-induced bullous eruption mimicking hand-foot syndrome and intertrigo-like eruption: rare cutaneous presentations and elusive pathogenesis.
    Ke CL; Chen CC; Lin CT; Chen GS; Chai CY; Cheng ST
    J Am Acad Dermatol; 2006 Aug; 55(2):355-6. PubMed ID: 16844531
    [No Abstract]   [Full Text] [Related]  

  • 16. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees.
    Franchini L; Serretti A; Gasperini M; Smeraldi E
    J Psychiatr Res; 1998; 32(5):255-9. PubMed ID: 9789202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study.
    Terra JL; Montgomery SA
    Int Clin Psychopharmacol; 1998 Mar; 13(2):55-62. PubMed ID: 9669185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluoxetine versus fluvoxamine for treatment of chronic pain].
    Ciaramella A; Grosso S; Poli P
    Minerva Anestesiol; 2000; 66(1-2):55-61. PubMed ID: 10736983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvoxamine for postpartum depression.
    Suri R; Burt VK; Altshuler LL; Zuckerbrow-Miller J; Fairbanks L
    Am J Psychiatry; 2001 Oct; 158(10):1739-40. PubMed ID: 11579021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.